HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

John Lyons Selected Research

Cytoreduction Surgical Procedures

12/2009Lymphatic mapping helps to define resection margins for midgut carcinoids.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


John Lyons Research Topics

Disease

18Neoplasms (Cancer)
05/2023 - 12/2003
3Ovarian Neoplasms (Ovarian Cancer)
02/2023 - 12/2014
3Neuroendocrine Tumors (Neuroendocrine Tumor)
12/2010 - 07/2008
2Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2015 - 08/2012
2Leukemia
06/2014 - 03/2004
2Hematologic Neoplasms (Hematological Malignancy)
03/2004 - 12/2003
1T-Cell Lymphoma (Lymphoma, T Cell)
10/2021
1Diarrhea
12/2020
1Fatigue
12/2020
1Nausea
12/2020
1Mucositis
12/2020
1Vomiting
12/2020
1Triple Negative Breast Neoplasms
01/2018
1Hemorrhage
08/2017
1Hepatocellular Carcinoma (Hepatoma)
10/2016
1Inflammation (Inflammations)
10/2016
1Liver Cirrhosis (Hepatic Cirrhosis)
10/2016
1Fatty Liver
10/2016
1Fibrosis (Cirrhosis)
10/2016
1Carcinogenesis
08/2015
1Primary Myelofibrosis (Myelosclerosis)
06/2014
1Lung Neoplasms (Lung Cancer)
03/2012
1Carcinoma (Carcinomatosis)
03/2012
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2012
1Carcinoid Tumor (Carcinoid)
07/2008
1Body Weight (Weight, Body)
07/2008
1Pain (Aches)
06/2007
1Chronic Pancreatitis
06/2007

Drug/Important Bio-Agent (IBA)

6Proteins (Proteins, Gene)FDA Link
02/2023 - 03/2012
5(2,4- dihydroxy- 5- isopropylphenyl)- (5- (4- methylpiperazin- 1- ylmethyl)- 1,3- dihydroisoindol- 2- yl)methanoneIBA
12/2020 - 03/2012
3guadecitabineIBA
01/2018 - 12/2014
3DecitabineFDA Link
10/2016 - 12/2003
2MethyltransferasesIBA
01/2018 - 12/2003
2DNA (Deoxyribonucleic Acid)IBA
01/2018 - 10/2016
2Histones (Histone)IBA
10/2016 - 06/2009
2Heat-Shock Proteins (Heat-Shock Protein)IBA
08/2015 - 03/2012
2Imatinib Mesylate (Gleevec)FDA Link
01/2015 - 08/2012
2Aurora KinasesIBA
06/2014 - 06/2009
1CaspasesIBA
02/2023
1Histone Deacetylase InhibitorsIBA
02/2023
1birinapantIBA
02/2023
1ASTX-660IBA
10/2021
1Inhibitor of Apoptosis ProteinsIBA
10/2021
1Biomarkers (Surrogate Marker)IBA
12/2020
14- (2,6- dichlorobenzoylamino)- 1H- pyrazole- 3- carboxylic acid piperidin-4-ylamideIBA
12/2020
1talazoparibIBA
01/2018
1Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2018
1Drug CombinationsIBA
01/2018
1omega-Chloroacetophenone (Mace)IBA
08/2017
1TicagrelorIBA
08/2017
1Prasugrel HydrochlorideFDA Link
08/2017
1Clopidogrel (Plavix)FDA Link
08/2017
1Molecular Chaperones (Chaperone, Molecular)IBA
08/2015
1Rifabutin (Ansamycin)FDA Link
01/2015
1PlatinumIBA
12/2014
1Cisplatin (Platino)FDA LinkGeneric
12/2014
1Transcription Factors (Transcription Factor)IBA
12/2014
1DNA AdductsIBA
12/2014
1Aurora Kinase AIBA
06/2014
11- cyclopropyl- 3- (3- (5- morpholin- 4- ylmethyl- 1H- benzoimidazol- 2- yl)- 1H- pyrazol- 4- yl)ureaIBA
06/2014
1epothilone B (EPO906)IBA
06/2012
1vatalanib (PTK787)IBA
06/2012
1Factor VIII (Coagulation Factor VIII)IBA
05/2012
1SynaptophysinIBA
05/2012
1Chromogranin AIBA
05/2012
1SaltsIBA
03/2012
1Lactic Acid (Lactate)FDA LinkGeneric
03/2012
1Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
09/2011
1Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
09/2011
1Indicators and Reagents (Reagents)IBA
12/2010
1Aurora Kinase BIBA
06/2009
1Octreotide (Sandostatin)FDA LinkGeneric
07/2008
1ras ProteinsIBA
08/2005
1Sorafenib (BAY 43-9006)FDA Link
08/2005
1mirdametinibIBA
08/2005
1Cytotoxins (Cytolysins)IBA
12/2003
1A-Form DNA (A-DNA)IBA
12/2003

Therapy/Procedure

3Therapeutics
01/2018 - 06/2007
2Aftercare (After-Treatment)
08/2012 - 03/2012
1Neoadjuvant Therapy
05/2023
1Esophagectomy
05/2023
1Cytoreduction Surgical Procedures
12/2009